首页> 外国专利> INDICES FOR MANAGEMENT OF DRY EYE SYNDROME, CORNEAL ECTASIA, KERATOPLASTY GRAFT REJECTION AND FAILURE AND FUCHS' DYSTROPHY

INDICES FOR MANAGEMENT OF DRY EYE SYNDROME, CORNEAL ECTASIA, KERATOPLASTY GRAFT REJECTION AND FAILURE AND FUCHS' DYSTROPHY

机译:干眼症候群,角膜异位症,角膜增生移植物排斥和失败及FUHSS营养不良的管理指数

摘要

Improved indices for the diagnosis and evaluation of conditions affecting the eye. Specifically, the indices include an Enhanced Epithelial Irregularity Factor (eEIF) for the diagnosis and evaluation of conditions such as dry eye syndrome (DES), Bowman's Ectasia Index (BEI), including enhanced BEI (eBEI) and BEI-Max, and Bowman's Relative Thinning (BRT) Index for the diagnosis and evaluation of ectatic conditions such as keratoconus, pellucid marginal degeneration, post-refractive surgery ectasia, and keratoglobus, and Descemet's Membrane Thickening Index (DMT), Descemet's Rejection Index (DRI), and Descemet's Membrane Irregularity Factor (DIF) for the diagnosis and evaluation of conditions such as keratoplasty rejection and failure and Fuchs' dystrophy. These improved indices may be incorporated into optical coherence tomography systems, or any other imaging device capable of capturing high resolution images of the cornea, for more sensitive and specific diagnosis, treatment, and monitoring of certain corneal conditions, in addition to the evaluation of new treatments.
机译:诊断和评估影响眼睛的状况的改进指标。具体而言,这些指标包括用于诊断和评估诸如干眼症候群(DES)等病症的增强上皮不规则因子(eEIF),包括增强BEI(eBEI)和BEI-Max的Bowman's Ectasia Index(BEI),以及Bowman's Relative用于诊断和评估圆锥角膜,透明边缘变性,屈光手术后扩张性角膜炎和角膜球囊扩张等直肠疾病的稀释指数(BRT),以及Descemet的膜增厚指数(DMT),Descemet的排斥指数(DRI)和Descemet的膜性变性诊断和评估状况的因素(DIF),例如角膜移植排斥反应和衰竭以及Fuchs营养不良。这些改进的指标可以结合到光学相干断层扫描系统或任何其他能够捕获角膜高分辨率图像的成像设备中,以进行更敏感,更具体的诊断,治疗和某些角膜状况的监测,此外还可以评估新的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号